Khalid Almutairi

Dr. Khalid Almutairi is a Research Fellow at the University of Western Australia (UWA) Medical School in the Emergency Medicine department. He holds a PhD from UWA Medical School, a Master of Clinical Pharmacy, and a Master of Health Administration from Curtin University. Previously, he worked as a senior clinical pharmacist in Intensive Care at King Fahd Specialist Hospital in Saudi Arabia for over seven years. His research focuses on rheumatoid arthritis epidemiology, healthcare cost analysis, and drug safety, contributing to UN Sustainable Development Goals. He has conducted extensive systematic reviews and meta-analyses on topics like interstitial lung disease prevalence in rheumatoid arthritis patients and biosimilar efficacy in ankylosing spondylitis.

Education:

• PhD in Medical Science, University of Western Australia
• MClinPharm (Master of Clinical Pharmacy), Curtin University
• M.H.A (Master of Health Administration), Curtin University
• BS Pharm (Bachelor of Pharmacy)

Research Interests:

• Rheumatoid Arthritis Clinical Epidemiology
• Health Economics and Cost-Burden Analysis
• Pharmacovigilance and Adverse Drug Reactions
• Systematic Reviews & Meta-Analyses Methodology
• Biological Therapies and Biosimilars

Publications Trends: His work emphasizes global prevalence studies of rheumatological comorbidities (e.g., osteoporosis, interstitial lung disease), drug safety in antirheumatic therapies, and longitudinal trends in rheumatoid arthritis mortality and hospitalization. Over 18 peer-reviewed articles demonstrate methodological rigor in meta-analyses and real-world data analysis.

Grants/Advising: No formal student advisees listed, but his research collaborations include institutions in Australia and Saudi Arabia. Funding sources may relate to health economics and clinical pharmacy studies.

Labs/Teams: Not explicitly mentioned, but collaborations with rheumatology and clinical pharmacy teams at UWA and Curtin University are implied through co-authored works.